Previous Close | 73.64 |
Open | 73.62 |
Bid | 73.29 x 800 |
Ask | 73.35 x 800 |
Day's Range | 73.10 - 73.96 |
52 Week Range | 43.39 - 75.98 |
Volume | |
Avg. Volume | 794,770 |
Market Cap | 10.005B |
Beta (5Y Monthly) | 1.17 |
PE Ratio (TTM) | 365.85 |
EPS (TTM) | 0.20 |
Earnings Date | Nov 05, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 79.54 |
AUDUBON, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, is participating in the 40th Annual Meeting of the Orthopedic Trauma Association (OTA) in Montréal, Canada, October 23—26. Join Globus at booth #361 during OTA for product demonstrations of the PRECICE™ technologies and our full orthopedic trauma product portfolio. Special highlights include our most recent additions to the portfolio including TENSOR™ Suture Button, ANT
AUDUBON, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2024 after the market close on Tuesday, November 5, 2024. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com. Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4